Skip to content
DataLookout
Menu

NCT07898384

Optimizing Care Transitions in CHD

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Start date changed from estimate of Sep 2026 to Nov 3, 2026
    • Site details revised
    • Collaborators: 1 to 9
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Recruitment and withdrawal rates
Timeframe: 12 weeks
Adherence
Timeframe: 12 weeks
Acceptability/Level of engagement
Timeframe: 12 weeks
Barriers/Enablers
Timeframe: 12 weeks

Secondary (12)

Perceived social role satisfaction (young adult mentor outcome)
Emotional distress (young adult mentor outcome)
Perceived social role satisfaction (parent mentor outcome)
Emotional distress (parent mentor outcome)
Transition readiness (adolescent/young adult mentee outcome)
Show 7 moreShow less
Perceived social support (adolescent/young adult mentee outcome)
Emotional distress (adolescent/young adult mentee outcome)
Mentor quality (adolescent/young adult mentee outcome)
Emotional distress (parent mentee outcome)
Coping (parent mentee outcome)
Mentor quality (parent mentee outcome)
Perceived social support (parent mentee outcome)

Arms and interventions

Intervention groupExperimental

In addition to their standard medical care, mentees in the experimental group will receive mentorship and support via the iP2P/iParent2Parent program. Trained mentors will provide information and support to mentee participants to encourage participation in self-management skill-building tailored to their needs. Each mentor will work with no more than two mentees at once for the study. Efforts will be made to pair mentors and mentees who share similar characteristics (e.g., similar disease severity, symptom profile, treatment regimen experiences, caregiver role, sex/gender, geographic area of residence). To ensure safety, a member of the research team will monitor all calls and messaging conversations as well as intervene in any potential safety concerns (e.g., discussion of suicidal ideation) or inappropriate behavior (e.g. bullying).

Waitlist control groupNo intervention

The control group will receive standard care without the iP2P/iParent2Parent intervention. The control group will be offered the iP2P/iParent2Parent intervention after completion of all outcome measures for a period of 12 weeks with the same research team support.

Behavioral: Peer mentorship

Sites

1 site in 1 country

  • The Hospital for Sick ChildrenToronto, Ontario, Canada